Breathe Well Live Well
|
Maxwell Biotech Venture Fund Invests in Pivotal Clinical Trial of Oxagen's …
Laser Focus world Maxwell Biotech Venture Fund (MBVF), founded with the help of Russian government-backed RVC, announced today that its investment committee approved the terms and the amount of an investment in Eleventa, a Russian biotech company, which was … |
View full post on asthma – Google News
 Proactive Investors USA & Canada |
AstraZeneca to join Rigel in asthma drug venture
The News Journal AstraZeneca will join with Rigel Pharmaceutical Inc. to develop a treatment for chronic asthma that could be worth $100 million, if the drug can manage the … AstraZeneca partners with Rigel on asthma drug AstraZeneca and Rigel strike asthma deal worth up to $100M AstraZeneca And Rigel Sign Worldwide License Agreement For A … |
View full post on asthma – Google News
|
Joint Venture Announced
GlobeNewsWire (press release) We are very pleased to be joining with MediciNova in providing better solutions for asthma patients" MN-221 is a novel, highly selective, beta2-adrenergic receptor agonist in development as an intravenous treatment for acute exacerbations of asthma and … |
View full post on asthma – Google News